The increasing demand for high-quality mRNA therapeutics highlights the importance of manufacturing and analytical solutions that safeguard product integrity, efficacy, and regulatory compliance. Exothera supports these needs through the Ntensify™ mRNA platform, a scalable, GMP-compliant solution designed to streamline production while integrating analytics at every step. By internalizing key analytical capabilities, lead times can be reduced and critical quality attributes monitored efficiently across different development stages.

In this article, we show how Exothera applies advanced analytical technologies and orthogonal strategies to support the reliable production, testing, and release of mRNA therapeutics across various stages of development.